The use of novel waveforms, frequencies, and stimulation modes in spinal cord stimulation (SCS) therapies may be more effective at relieving chronic low back pain and/or leg pain compared with traditional tonic low-frequency SCS.
For certain patients with complex pain patterns, stimulating both dorsal root ganglion and dorsal columns may relieve pain effectively.
Physicians who receive direct pharmaceutical payments for opioid prescribing prescribe more opioids, especially hydrocodone and oxycodone.
For patients with chronic pain (CP), both mindfulness-based stress reduction (MBSR) and cognitive behavioral therapy (CBT) improve physical functioning, pain intensity, and depression.
The percentage of individuals prescribed an opioid is higher in rural than urban areas.
Apadaz was initially approved in February 2018 as 6.12mg/325mg immediate-release tablets for the short-term (no more than 14 days) management of acute pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.
An ultrarestrictive opioid prescription protocol can reduce the number of opioids prescribed to patients after gynecologic and abdominal surgery without negative health consequences.
Military patients whose primary care clinicians participated in a telementoring program have larger declines in opioid-related prescriptions than patients whose clinicians did not participate.
The vote was taken in a joint meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and Drug Safety and Risk Management Advisory Committee.
The FDA has issued a safety communication regarding the risks associated with implanted pumps for intrathecal administration of pain medications.